Furthermore, high expression of GREM1 correlated with a poor prognosis in all the breast cancer molecular subtypes examined: human EGF receptor (HER)2+, triple−, estrogen receptor (ER)+, and ER− (Additional file 2: Figure S1b-e). Here, GREM1 is linked to breast cancer.